NCT00113958View on ClinicalTrials.gov

Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
End Stage Renal Disease
Interventions
DRUG

Cinacalcet

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00113958 - Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels | Biotech Hunter | Biotech Hunter